on behalf of the TARGET Study Group. Comparison of lumiracoxib with naproxen and ibuprofen in the Thera- peutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial - Farkouh, ME; Kirshner, H; Harrington, RA (Lancet, 2004)
et al.